Column Capital Advisors, LLC Moderna, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 117,112 shares of MRNA stock, worth $7.49 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
117,112
Previous 117,112
-0.0%
Holding current value
$7.49 Million
Previous $14.2 Million
14.99%
% of portfolio
0.63%
Previous 0.69%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
1,113Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.78 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.53 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.63 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$960 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$462 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $25B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...